Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 86

1.

Soluble VEGFR-1 secreted by endothelial cells and monocytes is present in human serum and plasma from healthy donors.

Barleon B, Reusch P, Totzke F, Herzog C, Keck C, Martiny-Baron G, Marmé D.

Angiogenesis. 2001;4(2):143-54.

PMID:
11806246
2.

Detection and quantification of complexed and free soluble human vascular endothelial growth factor receptor-1 (sVEGFR-1) by ELISA.

Hornig C, Behn T, Bartsch W, Yayon A, Weich HA.

J Immunol Methods. 1999 Jun 24;226(1-2):169-77.

PMID:
10410982
3.

Release and complex formation of soluble VEGFR-1 from endothelial cells and biological fluids.

Hornig C, Barleon B, Ahmad S, Vuorela P, Ahmed A, Weich HA.

Lab Invest. 2000 Apr;80(4):443-54.

PMID:
10780661
4.

Vascular endothelial growth factor-mediated decrease in plasma soluble vascular endothelial growth factor receptor-2 levels as a surrogate biomarker for tumor growth.

Ebos JM, Lee CR, Bogdanovic E, Alami J, Van Slyke P, Francia G, Xu P, Mutsaers AJ, Dumont DJ, Kerbel RS.

Cancer Res. 2008 Jan 15;68(2):521-9. doi: 10.1158/0008-5472.CAN-07-3217.

5.

Expression of soluble vascular endothelial growth factor receptor-1 in human monocyte-derived mature dendritic cells contributes to their antiangiogenic property.

Kishuku M, Nishioka Y, Abe S, Kishi J, Ogino H, Aono Y, Azuma M, Kinoshita K, Batmunkh R, Makino H, Ranjan P, Minakuchi K, Sone S.

J Immunol. 2009 Dec 15;183(12):8176-85. doi: 10.4049/jimmunol.0803849. Erratum in: J Immunol. 2010 Aug 15;185(4):2630. Rentsenhand, Batmungh [corrected to Batmunkh, Rentsenkhand].

6.

Regulation of vascular endothelial growth factor bioactivity in patients with acute lung injury.

Perkins GD, Roberts J, McAuley DF, Armstrong L, Millar A, Gao F, Thickett DR.

Thorax. 2005 Feb;60(2):153-8.

7.

Role of soluble vascular endothelial growth factor receptor-1 in the vitreous in proliferative diabetic retinopathy.

Matsunaga N, Chikaraishi Y, Izuta H, Ogata N, Shimazawa M, Matsumura M, Hara H.

Ophthalmology. 2008 Nov;115(11):1916-22. doi: 10.1016/j.ophtha.2008.06.025. Epub 2008 Aug 21.

PMID:
18718666
8.
9.

Circulating VEGF and its soluble receptors sVEGFR-1 and sVEGFR-2 in patients with acute leukemia.

Wierzbowska A, Robak T, Wrzesień-Kuś A, Krawczyńska A, Lech-Marańda E, Urbańska-Ryś H.

Eur Cytokine Netw. 2003 Jul-Sep;14(3):149-53.

10.

Poor responder-high responder: the importance of soluble vascular endothelial growth factor receptor 1 in ovarian stimulation protocols.

Neulen J, Wenzel D, Hornig C, Wünsch E, Weissenborn U, Grunwald K, Büttner R, Weich H.

Hum Reprod. 2001 Apr;16(4):621-6.

PMID:
11278207
11.

A naturally occurring soluble form of vascular endothelial growth factor receptor 2 detected in mouse and human plasma.

Ebos JM, Bocci G, Man S, Thorpe PE, Hicklin DJ, Zhou D, Jia X, Kerbel RS.

Mol Cancer Res. 2004 Jun;2(6):315-26.

12.
14.

Regulation of soluble vascular endothelial growth factor receptor 1 secretion from human endothelial cells by tissue inhibitor of metalloproteinase 1.

Bruegmann E, Gruemmer R, Neulen J, Motejlek K.

Mol Hum Reprod. 2009 Nov;15(11):749-56. doi: 10.1093/molehr/gap053. Epub 2009 Jul 7.

PMID:
19584194
15.

[The relativity of vascular endothelium growth factor receptor-1 and preeclampsia].

Zou CL, Liu XH, Yue BM, Fu JH, He GL.

Sichuan Da Xue Xue Bao Yi Xue Ban. 2006 Sep;37(5):765-8. Chinese.

PMID:
17037747
16.

Regulation of soluble VEGFR-2 secreted by microvascular endothelial cells derived from human BPH.

Aweimer A, Stachon T, Tannapfel A, Köller M, Truss MC, Stachon A.

Prostate Cancer Prostatic Dis. 2012 Jun;15(2):157-64. doi: 10.1038/pcan.2011.63. Epub 2011 Dec 20.

PMID:
22183775
17.

Plasma VEGF and soluble VEGF receptor FLT-1 in proliferative retinopathy: relationship to endothelial dysfunction and laser treatment.

Lip PL, Belgore F, Blann AD, Hope-Ross MW, Gibson JM, Lip GY.

Invest Ophthalmol Vis Sci. 2000 Jul;41(8):2115-9.

PMID:
10892852
18.

The maternal plasma soluble vascular endothelial growth factor receptor-1 concentration is elevated in SGA and the magnitude of the increase relates to Doppler abnormalities in the maternal and fetal circulation.

Chaiworapongsa T, Espinoza J, Gotsch F, Kim YM, Kim GJ, Goncalves LF, Edwin S, Kusanovic JP, Erez O, Than NG, Hassan SS, Romero R.

J Matern Fetal Neonatal Med. 2008 Jan;21(1):25-40. doi: 10.1080/14767050701832833.

PMID:
18175242
19.

Levels of soluble vascular endothelial growth factor (VEGF) receptor 1 in astrocytic tumors and its relation to malignancy, vascularity, and VEGF-A.

Lamszus K, Ulbricht U, Matschke J, Brockmann MA, Fillbrandt R, Westphal M.

Clin Cancer Res. 2003 Apr;9(4):1399-405.

20.

Estrogen and selective estrogen receptor modulators regulate vascular endothelial growth factor and soluble vascular endothelial growth factor receptor 1 in human endometrial stromal cells.

Okada H, Tsutsumi A, Imai M, Nakajima T, Yasuda K, Kanzaki H.

Fertil Steril. 2010 May 15;93(8):2680-6. doi: 10.1016/j.fertnstert.2009.08.056. Epub 2009 Oct 13.

PMID:
19828145

Supplemental Content

Support Center